Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GYRE

GYRE THERAPEUTICS, INC.

CIK 0001124105 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$6.91
↓ 0.11 (-1.57%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Excluded: Options (no data)

Key stats

Market Cap
$732.69M
P/E Ratio
-37.46
EPS
0.06
Dividend Yield
Not covered
52W Position
37%
Beta
1.19

Valuation multiples

Fwd P/E
78.12
PEG
Not covered
P/B
5.14
P/S
6.14
EV/Revenue
5.77
ROE
-13.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 37%
$5.44$9.42

Latest Financials

2025-12-31 FY
Revenue
$116.59M
Net Income
$9.88M
Total Assets
$166.13M
Free Cash Flow
-$180.00K

Recent news